PetMed Express Net Worth
PetMed Express Net Worth Breakdown | PETS |
PetMed Express Net Worth Analysis
PetMed Express' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including PetMed Express' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of PetMed Express' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform PetMed Express' net worth analysis. One common approach is to calculate PetMed Express' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares PetMed Express' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing PetMed Express' net worth. This approach calculates the present value of PetMed Express' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of PetMed Express' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate PetMed Express' net worth. This involves comparing PetMed Express' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into PetMed Express' net worth relative to its peers.
Enterprise Value |
|
To determine if PetMed Express is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PetMed Express' net worth research are outlined below:
| PetMed Express is way too risky over 90 days horizon | |
| PetMed Express appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 281.06 M. Net Loss for the year was (7.46 M) with profit before overhead, payroll, taxes, and interest of 78.08 M. | |
| Latest headline from globenewswire.com: PetMeds Adopts Limited Duration Shareholder Rights Plan |
PetMed Express uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PetMed Express. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PetMed Express' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 5th of February 2024 Upcoming Quarterly Report | View | |
| 27th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Know PetMed Express' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PetMed Express is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PetMed Express backward and forwards among themselves. PetMed Express' institutional investor refers to the entity that pools money to purchase PetMed Express' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 212.4 K | Millennium Management Llc | 2024-09-30 | 207.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 205.6 K | Invenomic Capital Management, Lp | 2024-09-30 | 172.7 K | Amvescap Plc. | 2024-09-30 | 149.8 K | Ameriprise Financial Inc | 2024-09-30 | 146.4 K | Man Group Plc | 2024-09-30 | 138.2 K | T. Rowe Price Associates, Inc. | 2024-09-30 | 130.1 K | Two Sigma Advisers, Llc | 2024-09-30 | 106.4 K | Renaissance Technologies Corp | 2024-09-30 | 1.3 M | Hotchkis & Wiley Capital Management Llc | 2024-09-30 | 1.1 M |
Follow PetMed Express' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 103.11 M.Market Cap |
|
Project PetMed Express' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.05) | |
| Return On Capital Employed | (0.08) | (0.08) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.08) | (0.07) |
When accessing PetMed Express' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures PetMed Express' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of PetMed Express' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in PetMed Express' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of PetMed Express. Check PetMed Express' Beneish M Score to see the likelihood of PetMed Express' management manipulating its earnings.
Evaluate PetMed Express' management efficiency
Return On Tangible Assets is likely to gain to -0.05 in 2024. Return On Capital Employed is likely to gain to -0.08 in 2024. At this time, PetMed Express' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 5.5 M in 2024, whereas Total Current Assets are likely to drop slightly above 79 M in 2024. PetMed Express' management efficiency ratios could be used to measure how well PetMed Express manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.74 | 2.81 | |
| Tangible Book Value Per Share | 2.89 | 2.72 | |
| Enterprise Value Over EBITDA | (37.62) | (35.74) | |
| Price Book Value Ratio | 0.99 | 0.94 | |
| Enterprise Value Multiple | (37.62) | (35.74) | |
| Price Fair Value | 0.99 | 0.94 | |
| Enterprise Value | 41.6 M | 39.5 M |
Understanding the operational decisions made by PetMed Express management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 0.1682 | Revenue 259.3 M | Quarterly Revenue Growth (0.16) | Revenue Per Share 12.654 | Return On Equity (0.01) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PetMed Express insiders, such as employees or executives, is commonly permitted as long as it does not rely on PetMed Express' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PetMed Express insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
PetMed Express Corporate Filings
| 3rd of December 2024 Other Reports | ViewVerify | |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 6th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
PetMed Express Earnings per Share Projection vs Actual
PetMed Express Corporate Management
| Mark Moseley | Chief Officer | Profile | |
| Carla Dodds | Chief Officer | Profile | |
| Matthew Hulett | Pres CEO | Profile | |
| Umesh Sripad | Chief Officer | Profile | |
| Christine Chambers | Treasurer Secretary | Profile |
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.